KRTAP9-12P

Across TCGA pan-cancer cohorts, KRTAP9-12P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of KRTAP9-12P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where KRTAP9-12P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRTAP9-12P is over-expressed in tumor.

HNSC, LUAD, and PRAD are the cancer types where KRTAP9-12P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRTAP9-12P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.044	.039	3	view →
LUAD	All	All	+0.060	.034	2	view →
PRAD	All	All	+0.034	.019	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

KRTAP9-12P–HNSC

Open the HNSC breakdown →